SOX2 as a novel contributor of oxidative metabolism in melanoma cells.
Elena AndreucciSilvia PietrobonoSilvia PeppicelliJessica RuzzoliniFrancesca BianchiniAlessio BiagioniBarbara SteccaLido CaloriniPublished in: Cell communication and signaling : CCS (2018)
SOX2 contributes to the acquisition of an aggressive oxidative tumor phenotype, endowed with enhanced drug resistance and metastatic ability.